J. Maas et al., EVIDENCE FOR ATYPICAL ENDOTHELIN RECEPTORS AND FOR PRESENCE OF ENDOTHELIN-CONVERTING ENZYME-ACTIVITY IN THE MOUSE ISOLATED VAS-DEFERENS, European journal of pharmacology, 276(1-2), 1995, pp. 113-121
The endothelin receptors controlling sympathetic neurotransmission and
the presence of endothelin-converting enzyme were investigated in the
mouse vas deferens. Endothelin-1 or endothelin-3 (0.01-100 nM) enhanc
ed contractions evoked by field stimulation, yielding EC(50) (geometri
c mean and 95% confidence limits) of 0.7 nM (0.4-1.6) and 13.7 nM (10.
2-14.1) and E(max) (mean +/- S.E.M. increase in twitch tension, in mg/
10 mg wet tissue) of 473 +/- 35 and 520 +/- 51, respectively. The sele
ctive endothelin ET(B) receptor agonists IRL 1620 (Suc-[Glu(9),Ala(11,
15)]endothelin-1) and sarafotoxin S6e were inactive up to 100 nM. Resp
onses to endothelin-3 were progressively inhibited by the selective en
dothelin ET(A) receptor antagonist BQ-123 (cyclo[D-Trp-D-Asp-Pro-D-Val
-Leu]) (10, 30 and 100 nM). At 100 nM, BQ-123 almost abolished the res
ponse to endothelin-3 (100 nM). In contrast, at 100, 300 nM and 1 mu M
, BQ-123 shifted the curve to endothelin-1 to the right only 2-, 5- an
d 6-fold, respectively. The selective endothelin ET(B) receptor antago
nist BQ-788 ucyl-D-1-methyoxcarbonyltryptophanyl-D-norleucine) (100 nM
) did not modify responses to endothelin-1 or endothelin-3 (0.01-100 n
M). Big-endothelin-1 (0.3-30 nM) was 10-fold less potent than endothel
in-1 in increasing neurogenic responses (EC(50) 6.8 nM, 4.7-9.6; E(max
) 457 +/- 37 mg/10 mg wet tissue). Preincubation with phosphoramidon (
100 mu M) reduced responses to big-endothelin-1, but not endothelin-1.
Thus, endotherin-1 and endothelin-3 potently enhance sympathetic neur
otransmission in the mouse vas deferens via stimulation of BQ-788-inse
nsitive endothelin receptors, which are variably sensitive to blockade
by BQ-123. It remains to be clarified if these findings are due to th
e presence of an atypical population of endothelin receptors in this t
issue, or reflect the binding of endothelin-1 and endothelin-3 to dist
inct subdomains of a single sub-type of endothelin ET(A) receptor. Thi
s tissue also displays pronounced phosphoramidon-sensitive endothelin-
converting enzyme activity.